Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL

Richard Garand, Kheïra Beldjord, Hélène Cavé, +23

Leukemia

Hematological MalignancyFlow CytometryLymphoid NeoplasiaMedicineHematology +9

New parameters in erythrocyte counting. Value of histograms.

C. Fossat, M Holtzman David, J.‐R. Harle, +4

PubMed

Hematology SystemDiagnosisImmunophenotypingBlood CellIron Deficiency +14

Detection of Plasminogen Activator Inhibitor-1 (PAI-1) mRNA in Human Megakaryocytes by In Situ Hybridization

Marie‐Christine Alessi, Nathalie Chomiki, R Berthier, +3

Thrombosis and Haemostasis

Bone Marrow SmearsImmunologyBlood CellMolecular BiologyPathology +16

Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937

Franck Peiretti, C. Fossat, F Anfosso, +3

Blood

Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937

Franck Peiretti, C. Fossat, F Anfosso, +3

Blood

Methodological aspects of minimal residual disease assessment by flow cytometry in acute lymphoblastic leukemia: A French multicenter study

C. Fossat, Mikaël Roussel, Isabelle Arnoux, +14

Cytometry Part B Clinical Cytometry

Myelofibrosis in a child suffering from a hypereosinophilic syndrome with trisomy 8: Response to corticotherapy

Gérard Michel, Isabelle Thuret, A.M. Capodano, +5

Medical and Pediatric Oncology

Crossing of antinuclear antibodies and anti-leishmania antibodies

B. Granel, J. Serratrice, L. Swiader, +7

Lupus

Parasitic DiseaseVasculitisImmunologyPathologyImmunotherapy +14

Activation of Plasminogen Activator Inhibitor-1 Synthesis by Phorbol Esters in Human Promyelocyte HL-60

Sophie Lopez, Franck Peiretti, Pierre‐Emmanuel Morange, +6

Thrombosis and Haemostasis

Leukocyte Activation Study During Occlusive Arterial Disease of the Lower Limb

C. Fossat, David Fabre, Yves Alimi, +5

Journal of Cardiovascular Pharmacology